Mycosis fungoides, nitrogen mustard and skin cancer
- 1 July 1978
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 99 (1) , 61-63
- https://doi.org/10.1111/j.1365-2133.1978.tb01962.x
Abstract
The prevalence of epithelial cancer was determined in 202 patients with mycosis fungoides and the Sézary syndrome and was found to be 10.5%. In an attempt to establish a possible association with topically applied nitrogen mustard, it was noted that 4.0% of these patients had lesions prior to nitrogen mustard therapy (although over half subsequently developed further lesions) and 6.5% of the patients developed them de novo after therapy. In two patients in this latter group, malignancies developed in are as not usually associated with solar-induced cancer. These findings indicate that epidermal neoplasia is not uncommon in these patients and that nitrogen mustard may function as a carcinogen or a co-carcinogen.Keywords
This publication has 4 references indexed in Scilit:
- Non-melanoma skin cancer among caucasians in four areas of the United StatesCancer, 1974
- Prognostic signs and the management of the mycosis fungoidesCancer, 1973
- Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic toleranceCancer, 1973
- Multiple arsenical cancers of skin and internal organsCancer, 1953